Quantum biology in low level light therapy: death of a dogma.
Level 5 - mechanism / opinion, no new human data
Theoretical and mechanistic narrative review proposing a biophysical model without primary human trial data.
PubMed 32395484 · doi:10.21037/atm.2020.03.159
What was done
The authors conducted a theoretical analysis and narrative literature review evaluating the biophysical mechanisms underlying low-level light therapy (LLLT). They examined the traditional paradigm of cytochrome c oxidase as the primary mitochondrial photoacceptor and formulated an alternative quantum-biological model.
What was found
The abstract reports no numerical or quantitative experimental results. Conceptually, the authors describe a model where red and near-infrared light reduces the viscosity of nanoscopic interfacial water layers—functioning as the gate in a biological field-effect transistor between cytochrome c and cytochrome c oxidase—thereby promoting ATP synthesis in oxidatively stressed cells.
Why it matters
This paper proposes an alternative theoretical framework for photobiomodulation, shifting the focus from direct chromophore absorption by cytochrome c oxidase to interfacial water dynamics.
Limits
The paper is a theoretical and narrative review with no new primary clinical or empirical data reported in the abstract. The biological field-effect transistor model is hypothesis-generating and requires direct empirical validation.